Don’t Be Fooled, Biden Still Doesn’t Care About the Border
DOJ Makes Announcement Regarding Two Navy SEALs Who Died Intercepting Iranian Weapons
Day 1 of CPAC Was Amazing
Journalist Nails What the Russian Collusion Antics Signify for the Democratic Party
'What Fraud?': Shark Tank Host Rips Into NY Judge Over Rogue Judgement in...
Netanyahu's Plan for the 'Day After Hamas'
Another Automaker Hits the Brakes on Electric Vehicles
Biden's Not Just Using His Cheat Sheets at Press Conferences
NYT Has Bad News for Biden's Economic Claims
Here’s Why a Transgender Activist Was Arrested at a March for Life Event
Why the Democrats and Media Continue to Ignore Tony Bobulinski and His Evidence...
There’s More Illegal Immigrants From China Than Mexico at This Part of the...
Democrat Lawmakers in Blue State Introduce Reparations Package
Here's Why the Haley Campaign Is Pretty Excited About This New National Poll
Cori Bush's Campaign Continues to Be in Deep Trouble

New CDC Study Shows How Quickly Booster Effectiveness Wanes

AP Photo/Alastair Grant, File

A study released Friday by the U.S. Centers for Disease Control and Prevention shows that the booster shots of the Pfizer-BioNTech and Moderna vaccine lose substantial effectiveness after about four months but still provide protection against hospitalization.


According to the study, researchers found that boosters were effective against cases of moderate and severe COVID-19 for two months after the dose. The effectiveness dropped by the fourth month after the booster dose. But, the booster shots still provided protection in keeping people out of hospitals during the Delta and Omicron variant surge.

The booster was 91 percent effective in preventing a vaccinated person from COVID-19 hospitalization the first two months after receiving their booster shot. Four months after getting boosted, protection dropped to 78 percent. 

The study found that trips to urgent care and emergency departments fell from 87 percent in the first two months after getting boosted to 66 percent after four months. After more than five months after receiving the booster, protection dropped to 31 percent.

The study analyzed hospitalizations and emergency room and urgent care visits from 10 states from Aug. to Jan. 22, 2022. This span covers when Delta and Omicron were dominant. In the study, over 50 percent of people hospitalized were over 65 years old. 10 percent were boosted.


The Washington Post noted that “the report did not evaluate the variations in waning immunity by age, underlying health conditions, or a person’s immunocompromised status.”

The study suggested that more boosters may be needed in the future.

"These findings underscore the importance of receiving a third dose of mRNA COVID-19 vaccine to prevent both COVID-19–associated [emergency department and urgent care] encounters and COVID-19 hospitalizations among adults. The finding that protection conferred by mRNA vaccines waned in the months after receipt of a third vaccine dose reinforces the importance of further consideration of additional doses to sustain or improve protection against COVID-19–associated [emergency department and urgent care] encounters and COVID-19 hospitalizations," the study stated. 

"All eligible persons should remain up to date with recommended COVID-19 vaccinations to best protect against COVID-19–associated hospitalizations and ED/UC visits,” it added.

On Wednesday, Dr. Anthony Fauci, President Biden’s chief medical adviser, said during a White House COVID-19 briefing that decisions surrounding boosters would depend on “efficacy in preventing, for example, hospital visits, as well as hospitalizations.”


In September, two top U.S. Food and Drug Administration vaccine regulators, Dr. Marion Gruber and Dr. Philip Krause, departed their roles due to the Biden administration’s push for booster shots for the general public. In an article titled “Considerations in boosting COVID-19 vaccine immune responses,” Krause and Gruber, as well as other doctors, argued that “current evidence does not, therefore, appear to show a need for boosting in the general population, in which efficacy against severe disease remains high,” and that “the currently available evidence does not show the need for widespread use of booster vaccination in populations that have received an effective primary vaccination regimen.”

Join the conversation as a VIP Member


Trending on Townhall Videos